摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl [2-(4-chlorophenyl)-5-phenyl-1,3-thiazol-4-yl]acetate | 105584-38-1

中文名称
——
中文别名
——
英文名称
Ethyl [2-(4-chlorophenyl)-5-phenyl-1,3-thiazol-4-yl]acetate
英文别名
ethyl 2-[2-(4-chlorophenyl)-5-phenyl-1,3-thiazol-4-yl]acetate
Ethyl [2-(4-chlorophenyl)-5-phenyl-1,3-thiazol-4-yl]acetate化学式
CAS
105584-38-1
化学式
C19H16ClNO2S
mdl
——
分子量
357.9
InChiKey
YBNZZODQEOWZJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.9
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    67.4
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    Ethyl [2-(4-chlorophenyl)-5-phenyl-1,3-thiazol-4-yl]acetate甲醇 作用下, 以 甲醇 为溶剂, 反应 72.0h, 以to obtain 2-(4-chloro-phenyl)-5-phenylthiazol-4-yl acetamide (4.2 g)的产率得到2-(4-Chlorophenyl)-5-phenylthiazol-4-yl acetamide
    参考文献:
    名称:
    Large conductance calcium-activated K channel opener
    摘要:
    一种大导电性钙激活的K通道开放剂,其作为活性成分包含以下式子(I)所代表的含氮5元杂环化合物,其中X代表N—R4、O或S,R1和R2各自独立地代表氢、卤素、羧基、氨基、较低的烷基、较低的烷氧基羰基、较低的烯基、环-较低的烷基、氨基甲酰基、芳香族、杂环或杂环取代的羰基基团,R3代表芳香族、杂环或较低的烷基基团,而R4代表氢或较低的烷基基团,或其药学上可接受的盐。
    公开号:
    US07759373B2
点击查看最新优质反应信息

文献信息

  • Large conductance calcium-activated k channel opener
    申请人:——
    公开号:US20040127527A1
    公开(公告)日:2004-07-01
    A large conductance calcium-activated K channel opener comprising as an active ingredient a nitrogen-containing 5-membered heterocyclic compound represented by the following formula (I): 1 wherein X represents N—R 4 , O or S, R 1 and R 2 each independently represent hydrogen, halogen, carboxyl, amino, lower alkyl, lower alkoxycarbonyl, lower alkenyl, cyclo-lower alkyl, carbamoyl, aryl, heterocyclic or heterocyclic-substituted carbonyl group, R 3 represents aryl, heterocyclic or lower alkyl group, and R 4 represents hydrogen or lower alkyl group, or a pharmaceutically acceptable salt thereof.
    一种大导电性激活的K通道开放剂,包括以下式子(I)所表示的含氮5元杂环化合物作为活性成分:1其中,X代表N-R4,O或S,R1和R2各自独立地代表氢、卤素、羧基、基、低级烷基、低级烷氧羰基、低级烯基、环状低级烷基、基甲酰基、芳香族、杂环或杂环取代的羰基基团,R3代表芳香族、杂环或低级烷基基团,R4代表氢或低级烷基基团,或其药学上可接受的盐。
  • LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER
    申请人:Hongu Mitsuya
    公开号:US20100256165A1
    公开(公告)日:2010-10-07
    A large conductance calcium-activated K channel opener comprising as an active ingredient a nitrogen-containing 5-membered heterocyclic compound represented by the following formula (I): wherein X represents N—R 4 , O or S, R 1 and R 2 each independently represent hydrogen, halogen, carboxyl, amino, lower alkyl, lower alkoxycarbonyl, lower alkenyl, cyclo-lower alkyl, carbamoyl, aryl, heterocyclic or heterocyclic-substituted carbonyl group, R 3 represents aryl, heterocyclic or lower alkyl group, and R 4 represents hydrogen or lower alkyl group, or a pharmaceutically acceptable salt thereof.
    一种大导电性激活的K通道开放剂,其作为活性成分是一种含氮的5元杂环化合物,表示为以下式子(I):其中X代表N—R4,O或S,R1和R2各自独立地表示氢、卤素、羧基、基、低碳基、低碳氧基羰基、低烯基、环-低碳基、基甲酰基、芳基、杂环或杂环取代的羰基基团,R3表示芳基、杂环或低碳基团,R4表示氢或低碳基团,或其药学上可接受的盐。
  • IMIDAZOLE, THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR USE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT AND/OR PREVENTION OF POLLAKIURIA OR URINARY INCONTINENCE
    申请人:Tanabe Seiyaku Co., Ltd.
    公开号:EP1432690A2
    公开(公告)日:2004-06-30
  • US7759373B2
    申请人:——
    公开号:US7759373B2
    公开(公告)日:2010-07-20
  • [EN] LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER<br/>[FR] SUBSTANCE D'OUVERTURE DU CANAL K ACTIVEE PAR LE CALCIUM A GRANDE CONDUCTANCE
    申请人:TANABE SEIYAKU CO
    公开号:WO2002083111A2
    公开(公告)日:2002-10-24
    A large conductance calcium-activated K channel opener comprising as an active ingredient a nitrogen-containing 5-membered heterocyclic compound represented by the following formula (I): wherein X represents N-R4, O or S, R1 and R 2 each independently represent hydrogen, halogen carboxyl, amino, lower alkyl, lower alkoxycarbonyl, lower alkenyl, cyclo-lower alkyl, carbamoyl, aryl, heterocyclic or heterocyclic-substituted carbonyl group, R3 represents aryl, heterocyclic or lower alkyl group, and R4 represents hydrogen or lower alkyl group, or a pharmaceutically acceptable salt thereof and its use for the preparation of a medicament for the phophylaxis and/or treatment of pollakiuria or urinary incontinence.
查看更多